236 related articles for article (PubMed ID: 31740521)
1. A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
Murphy CC; Sen A; Watson B; Gupta S; Mayo H; Singal AG
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):278-287. PubMed ID: 31740521
[TBL] [Abstract][Full Text] [Related]
2. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
[TBL] [Abstract][Full Text] [Related]
3. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
5. Improving fecal occult blood testing compliance using a mailed educational reminder.
Lee JK; Reis V; Liu S; Conn L; Groessl EJ; Ganiats TG; Ho SB
J Gen Intern Med; 2009 Nov; 24(11):1192-7. PubMed ID: 19774423
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal adherence with fecal occult blood test screening in community practice.
Fenton JJ; Elmore JG; Buist DS; Reid RJ; Tancredi DJ; Baldwin LM
Ann Fam Med; 2010; 8(5):397-401. PubMed ID: 20843880
[TBL] [Abstract][Full Text] [Related]
9. Adherence to repeat fecal occult blood testing in an urban community health center network.
Liss DT; Petit-Homme A; Feinglass J; Buchanan DR; Baker DW
J Community Health; 2013 Oct; 38(5):829-33. PubMed ID: 23546555
[TBL] [Abstract][Full Text] [Related]
10. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
[TBL] [Abstract][Full Text] [Related]
11. Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.
Tinmouth J; Baxter NN; Paszat LF; Rabeneck L; Sutradhar R; Yun L
BMJ Open; 2014 Mar; 4(3):e004494. PubMed ID: 24622950
[TBL] [Abstract][Full Text] [Related]
12. Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.
van der Vlugt M; Grobbee EJ; Bossuyt PM; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Essink-Bot ML; Spaander MC; Dekker E
Br J Cancer; 2017 Jan; 116(1):44-49. PubMed ID: 27923037
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
14. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of a call-in centre to deliver colorectal cancer screening in primary care.
Sewitch MJ; Jiang M; Grad R; Yaffe M; Pavilanis A; Joseph L; Barkun AN; Roper M
Can Fam Physician; 2013 Dec; 59(12):e550-7. PubMed ID: 24336560
[TBL] [Abstract][Full Text] [Related]
16. Adherence to continuous screening for colorectal neoplasia.
Myers RE; Balshem AM; Wolf TA; Ross EA; Millner L
Med Care; 1993 Jun; 31(6):508-19. PubMed ID: 8501998
[TBL] [Abstract][Full Text] [Related]
17. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
18. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.
Baker DW; Brown T; Buchanan DR; Weil J; Cameron KA; Ranalli L; Ferreira MR; Stephens Q; Balsley K; Goldman SN; Wolf MS
BMC Health Serv Res; 2013 Apr; 13():153. PubMed ID: 23627550
[TBL] [Abstract][Full Text] [Related]
19. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]